Skip to main content

Opioids

Office of the Attor­ney Gen­er­al Reach­es $168 Mil­lion Set­tle­ment With Wal­mart Over Company’s Role in Nation­al Opi­oid Cri­sis and Encour­ages Local Areas to Sign On to Receive Funds

The Office of the Attorney General of Texas (“OAG”) finalized a settlement with Walmart for $168 million due to the company’s negligent practices that contributed to the nationwide opioid crisis.  

July 19, 2023 | Press Release

OAG Secures $300 Mil­lion for Texas in Opi­oid Set­tle­ment With CVS and Encour­ages Local Areas to Sign On to Receive Funds

The Office of the Attorney General (“OAG”) reached a $5 billion multistate settlement with CVS for the company’s role in the national opioid epidemic, including inadequately monitoring opioid prescriptions.

July 07, 2023 | Press Release

Pax­ton Secures $340 Mil­lion for Texas in Opi­oid Set­tle­ment With Walgreens

Attorney General Paxton announced a $5.7 billion settlement with Walgreens, with over $340 million designated for Texas, for their role in the nationwide opioid epidemic.

May 27, 2023 | Press Release

Pax­ton Secures Over $10 Bil­lion in Opi­oid Funds from CVS and Walgreens

Attorney General Paxton announced that Texas is joining finalized opioid agreements with CVS and Walgreens totaling $10.7 billion nationally, with CVS paying $5 billion and Walgreens paying $5.7 billion.

January 20, 2023 | Press Release

Pax­ton Announces that Texas Has Joined $2.37 Bil­lion Set­tle­ment With Opi­oid Man­u­fac­tur­er Allergan

Attorney General Paxton announced that Texas is joining a $2.37 billion settlement with opioid manufacturer Allergan for its role in the nationwide opioid epidemic.

January 20, 2023 | Press Release

Pax­ton Secures $168M for Texas in Opi­oid Agree­ment with Walmart

Attorney General Paxton announced a planned $3.1 billion settlement with Walmart, with over $168 million designated for Texas, for Walmart’s role in the nationwide opioid epidemic.

December 15, 2022 | Press Release

Pax­ton Urges Fed­er­al Gov­ern­ment to Pro­tect Access to Tele­health Option Enabling Peo­ple to Obtain Treat­ment for Opi­oid Use

Attorney General Paxton has joined a multistate letter urging the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) to permanently extend a Covid-era rule that allows individuals seeking opioid treatment to be prescribed buprenorphine via telemedicine appointments.  

December 09, 2022 | Press Release

Pax­ton Announces Agree­ment in Prin­ci­ple in Opi­oid Set­tle­ment with CVS Phar­ma­cy; Texas to Receive $276 mil­lion Under Pro­posed Deal

Attorney General Paxton announced plans to enter into a $5.034 billion multistate settlement with CVS Pharmacy for its role in the nationwide opioid epidemic, with over $276 million designated for Texas.

November 02, 2022 | Press Release

Pax­ton Launch­es Fri­day Night Lights Against Opi­oids” Coali­tion to Help Fight Opi­oid Epi­dem­ic, Espe­cial­ly Among Young Peo­ple and Stu­dent Athletes

Attorney General Ken Paxton has launched the “Friday Night Lights Against Opioids” coalition and a large-scale pilot program to help stop the opioid epidemic from destroying Texas communities and hurting our young people—especially student athletes.

October 12, 2022 | Press Release

AG Pax­ton Announces $2.37 Bil­lion Agree­ment to Set­tle with For­mer Opi­oid Maker

For the second time this week, Attorney General Paxton and a bipartisan group of attorneys general announced an agreement in principle to address the opioid crisis

July 29, 2022 | Press Release